Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterophilicity and cholesterol efflux via SR-BI

Biochemistry

Volumn 45, Issue 38, 2006, Pages 11514-11522

  Pownall, Henry J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CELLS; CHOLESTEROL; DETERGENTS; PHOSPHOLIPIDS; TISSUE;

CHOLESTEROL EFFLUX; LOW-DENSITY LIPOPROTEINS (LDL); PHOSPHOLIPIDATION; PLASMA LIPOPROTEINS;

PROTEINS;

CHOLESTEROL; DETERGENT; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; SCAVENGER RECEPTOR BI;

ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; PRIORITY JOURNAL; VALIDATION PROCESS;

ANIMALS; CHO CELLS; CHOLESTEROL; CHROMATOGRAPHY, GEL; CRICETINAE; CRICETULUS; DETERGENTS; HUMANS; KINETICS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MODELS, BIOLOGICAL; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; SCAVENGER RECEPTORS, CLASS B;

EID: 33748990619     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0608717     Document Type: Article

References (52)

1. Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease, N. Engl J. Med. 317, 1237-1245.
2. Manninen, V., Elo, M. O., Frick, M. H., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., et al. (1988) Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study, J. Am. Med. Assoc. 260, 641-651.
3. Rhoads, G. G., Gulbrandssen, C. L., and Kagan, A. (1976) Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men, N. Engl. J. Med. 294, 293-298.
4. Gordon, T., Hjortland, M., Kannel, W., and Dawber, T. (1977) High density lipoprotein as a protective factor against coronary heart disease: the Framingham study, Am. J. Med. 66, 707-714.
5. Miller, N. E., Thelle, D. S., Førde, O. H., and Mjøs, O. D. (1977) The Tromsø heart study: high-density lipoprotein and coronary heart-disease: a prospective case-control study, Lancet 1, 964-968.
6. Jacobs, D. R., Mebane, I. L., Bangdiwal, S. I., Criqui, M. H., and Tyroler, H. A. (1990) High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the lipid research clinics prevalence study, Am. J. Epidemiol. 131, 32-47.
7. Jian, B., de la Llera-Moya, M., Ji, Y., Wang, N., Phillips, M. C., Swaney, J. B., Tall, A. R., and Rothblat, G. H. (1998) Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors, J. Biol. Chem. 273, 5599-5606.
8. Fournier, N., de la Llera Moya, M., Burkey, B. F., Swaney, J. B., Paterniti, J., Jr., Moatti, N., Atger, V., and Rothblat, G. H. (1996) Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats, J. Lipid Res. 37, 1704-1711.
9. Jian, B., de la Llera-Moya, M., Royer, L., Rothblat, G. H., Francone, O., and Swaney, J. B. (1997) Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid, J. Lipid Res. 38, 734-744.
10. Yancey, P. G., de la Llera-Moya, M., Swarnakar, S., Monzo, P., Klein, S. M., Connelly, M. A., Johnson, W. J., Williams, D. L., and Rothblat, G. H. (2000) High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI, J. Biol. Chem. 275, 36596-36604.
11. Picardo, M., Massey, J. B., Kuhn, D. E., Gotto, A. M., Jr., Gianturco, S. H., and Pownall, H. J. (1986) Partially reassembled high density lipoproteins. Effects on cholesterol flux, synthesis, and esterification in normal human skin fibroblasts, Arteriosclerosis 6, 434-441.
12. Aron, L., Jones, S., and Fielding, C. J. (1978) Human plasma lecithin-cholesterol acyltransferase. Characterization of cofactor-dependent phospholipase activity, J. Biol. Chem. 253, 7220-7226.
13. Glomset, J. (1968) The plasma lecithin:cholesterol acyltransferase reaction, J. Lipid Res. 9, 155-167.
14. Yancey, P. G., Bortnick, A. E., Kellner-Weibel, G., de la Llera-Moya, M., Phillips, M. C., and Rothblat, G. H. (2003) Importance of different pathways of cellular cholesterol efflux, Arterioscler. Thromb. Vasc. Biol. 23, 712-719.
15. Hara, H., and Yokoyama, S. (1991) Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol, J. Biol. Chem. 266, 3080-3086.
16. Bielicki, J. K., Johnson, W. J., Weinberg, R. B., Glick, J. M., and Rothblat, G. H. (1992) Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol, J. Lipid Res. 33, 1699-709.
17. Francis, G. A., Knopp, R. H., and Oram, J. F. (1995) Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease, J. Clin. Invest. 96, 78-87.
18. Engel, T., Lorkowski, S., Lueken, A., Rust, S., Schluter, B., Berger, G., Cullen, P., and Assmann, G. (2001) The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages, Biochem. Biophys. Res. Commun. 288, 483-488.
19. Wang, N., Lan, D., Chen, W., Matsuura, F., and Tall, A. R. (2004) ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins, Proc. Natl. Acad. Sci. U.S.A. 101, 9774-9779.
20. Nakamura, K., Kennedy, M. A., Baldan, A., Bojanic, D. D., Lyons, K., and Edwards, P. A. (2004) Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein, J. Biol. Chem. 279, 45980-45989.
21. Pownall, H. J. (2005) Remodeling of human plasma lipoproteins by detergent perturbation, Biochemistry 44, 9714-9722.
22. Pownall, H. J., and Ehnholm, C. (2005) Enhancing reverse cholesterol transport: the case for phosphatidylcholine therapy, Curr. Opin. Lipidol. 16, 265-268.
23. Shumaker, V. N., and Puppione, D. L. (1986) Sequential flotation ultracentrifugation, Methods Enzymol. 128, 155-169.
24. Markwell, M. A., Haas, S. M., Bieber, L. L., and Tolbert, N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples, Anal. Biochem. 87, 206-210.
25. Niu, S. L., and Litman, B. J. (2002) Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system: effect of phospholipid acyl chain unsaturation and headgroup composition, Biophys J. 83, 3408-3415.
26. Pownall, H. J., Van Winkle, W. B., Pao, Q., Rohde, M., and Gotto, A. M., Jr. (1982) Action of lecithin:cholesterol acyltransferase on model lipoproteins. Preparation and characterization of model nascent high density lipoprotein, Biochim. Biophys. Acta 713, 494-503.
27. McKeone, B. J., Osmundsen, K., Brauchi, D., Pao, Q., Payton-Ross, C., Kilinc, C., Kummerow, F. A., and Pownall, H. J. (1997) Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia, J. Lipid Res. 38, 429-436.
28. de la Llera-Moya, M., Rothblat, G. H., Connelly, M. A., Kellner-Weibel, G., Sakr, S. W., Phillips, M. C., and Williams, D. L. (1999) Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface, J. Lipid Res. 40, 575-580.
29. Tanaka, A., Terasawa, T., Hagihara, H., Sakuma, Y., Ishibe, N., Sawada, M., Takasugi, H., and Tanaka, H. (1998) Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT). Part 1: identification and structure-activity relationships of a novel series of substituted N-alkyl-N-biphenylylmethyl- N′-arylureas, Bioorg. Med. Chem. 6, 15-30.
30. Massey, J. B., Hickson, D., She, H. S., Sparrow, J. T., Via, D. P., Gotto, A. M., Jr., and Pownall, H. J. (1984) Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins, Biochim. Biophys. Acta 794, 274-280.
31. Lund-Katz, S., Hammerschlag, B., and Phillips, M. C. (1982) Kinetics and mechanism of free cholesterol exchange between human serum high- and low-density lipoproteins, Biochemistry 21, 2964-2969.
32. Gauster, M., Oskolkova, O. V., Innerlohinger, J., Glatter, O., Knipping, G., and Frank, S. (2004) Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux, Biochem. J. 382 (Part 1), 75-82.
33. Smith, L. C., Massey, J. B., Sparrow, J. T., Gotto, A. M., Jr., and Pownall, H. J. (1983) Structure and dynamics of human plasma lipoproteins, in Supramolecular Structure and Function (Pifat, G., and Herak, J. N., Eds.) pp 205-244, Plenum Press, New York.
34. Thuahnai, S. T., Lund-Katz, S., Dhanasekaran, P., de la Llera-Moya, M., Connelly, M. A., Williams, D. L., Rothblat, G. H., and Phillips, M. C. (2004) Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure, J. Biol. Chem. 279, 12448-12455.
35. Day, C. (1975) Obstacles to the clinical investigation of phospholipids, Artery 1, 1-2.
36. Oram, J. F. (2003) HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol, Arterioscler. Thromb. Vasc. Biol. 23, 720-727.
37. Yancey, P. G., Bielicki, J. K., Johnson, W. J., Lund-Katz, S., Palgunachari, M. N., Anantharamaiah, G. M., Segrest, J. P., Phillips, M. C., and Rothblat, G. H. (1995) Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides, Biochemistry 34, 7955-7965.
38. Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., and Krieger, M. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science 271, 518-520.
39. Gelissen, I. C., Harris, M., Rye, K. A., Quinn, C., Brown, A. J., Kockx, M., Cartland, S., Packianathan, M., Kritharides, L., and Jessup, W. (2006) ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I, Arterioscler. Thromb. Vasc. Biol. 26, 534-540.
40. Phillips, M. C., Johnson, W. J., and Rothblat, G. H. (1987) Mechanisms and consequences of cellular cholesterol exchange and transfer, Biochim. Biophys. Acta 906, 223-276.
41. Phillips, M. C., Gillotte, K. L., Haynes, M. P., Johnson, W. J., Lund-Katz, S., and Rothblat, G. H. (1998) Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes, Atherosclerosis 137 (Suppl.), S13-S17.
42. Lund-Katz, S., Laboda, H. M., McLean, L. R., and Phillips M. C. (1988) Influence of molecular packing and phospholipid type on rates of cholesterol exchange, Biochemistry 27, 3416-3423.
43. Hajj Hassan, H., Blain, S., Boucher, B., Denis, M., Krimbou, L., and Genest, J. (2005) Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release, J. Lipid Res. 46, 1457-1465.
44. Cham, B. E., Kostner, K. M., Shafey, T. M., Smith, J. L., and Colquhoun, D. M. (2005) Plasma delipidation process induces rapid regression of atherosclerosis and mobilisation of adipose tissue, J. Clin. Apher. 20, 143-153.
45. Tall, A. R., and Small, D. M. (1977) Solubilisation of phospholipid membranes by human plasma high density lipoproteins, Nature 265, 163-164.
46. Pownall, H. J., Hickson-Bick, D., and Massey, J. B. (1991) Effects of hydrophobicity on turnover of plasma high density lipoproteins labeled with phosphatidylcholine ethers in the rat, J. Lipid Res. 32, 793-800.
47. Brewer, H. B., Remaley, A. T., Neufeld, E. B., Basso, F., and Joyce, C. (2004) Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease, Arterioscler. Thromb. Vasc. Biol. 24, 1755-1760.
48. Davidson, W. S., Gillotte, K. L., Lund-Katz, S., Johnson, W. J., Rothblat, G. H., and Phillips, M. C. (1995) The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol, J. Biol. Chem. 270, 5882-5890.
49. Matz, C. E., and Jonas, A. (1982) Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions, J. Biol. Chem. 257, 4535-4540.
50. Nanjee, M. N., Doran, J. E., Lerch, P. G., and Miller, N. E. (1999) Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans, Arterioscler. Thromb. Vasc. Biol. 19, 979-989.
51. Nanjee, M. N., Cooke, C. J., Garvin, R., Semeria, F., Lewis, G., Olszewski, W. L., and Miller, N. E. (2001) Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans, J. Lipid Res. 42, 1586-1593.
52. Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, J. Am. Med. Assoc. 290, 2292-300.